CVS CAREMARK CORPORATION $750,000,000 1.20% Senior Notes due 2016 $1,250,000,000 2.25% Senior Notes due 2018 $1,250,000,000 4.00% Senior Notes due 2023 $750,000,000 5.30% Senior Notes due 2043 Underwriting AgreementCVS Caremark Corp • December 5th, 2013 • Retail-drug stores and proprietary stores • New York
CVS Caremark Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $750,000,000 aggregate principal amount of its 1.20% Senior Notes due 2016 (the “2016 Notes”), $1,250,000,000 aggregate principal amount of its 2.25% Senior Notes due 2018 (the “2018 Notes”), $1,250,000,000 aggregate principal amount of its 4.00% Senior Notes due 2023 (the “2023 Notes”) and $750,000,000 aggregate principal amount of its 5.30% Senior Notes due 2043 (the “2043 Notes” and together with the 2016 Notes, the 2018 Notes and the 2023 Notes, (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Barclays Capital Inc. and J.P. Morgan Securities LLC are acting as representatives (the “Representatives”). The Notes will (i) have terms and provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section 1(a) hereof) and (ii) be issued pursuant to an Inde
